CLK1 and ovarian cancer: CLK2 inhibition changes the expression and alternative splicing of EMT-associated genes in breast cancer27, and the activation of the splice factor SPF45 following its phosphorylation by CLK1 promotes cancer cell line migration and invasion of ovarian cancer cells40.